Choriocarcinoma in neonates and infants: A severe but curable disease.
Marie Pierre CastexJoanna StefanowiczLaura ClementJadwiga Węcławek-TompolFrederic HameuryBrice FresneauSabine IrtanAnne Cecile BrunacDanuta Januszkiewicz-LewandowskaBrigitte LacourCécile Faure-ConterDaniel OrbachPublished in: Pediatric blood & cancer (2024)
Choriocarcinoma in neonates and infants (N-CC) is an extremely rare, but aggressive cancer, frequently observed with concomitant maternal disease. A retrospective, bi-national study of patients treated in France and Poland for infantile choriocarcinoma analysed eight cases of N-CC, median age of 6 weeks. All tumours were diffuse. Six patients received a platinum-based regimen, and five had delayed surgery on residual distant tumour sites. At the end of follow-up, four patients were in complete remission and four had died of the disease. In all but two cases, mothers had simultaneous metastatic choriocarcinoma. Even if the outcome remains poor, patients could be cured with multimodal therapy.
Keyphrases
- end stage renal disease
- newly diagnosed
- ejection fraction
- chronic kidney disease
- prognostic factors
- squamous cell carcinoma
- peritoneal dialysis
- small cell lung cancer
- stem cells
- patient reported outcomes
- rheumatoid arthritis
- body mass index
- acute coronary syndrome
- preterm infants
- bone marrow
- mesenchymal stem cells
- cell therapy
- low birth weight
- lymph node metastasis
- surgical site infection
- papillary thyroid